Predicting the clinical course of prostate cancer

AUTOR(ES)

McKiernan, James

FONTE

American Society for Clinical Investigation

RESUMO

Risk stratification in prostate cancer remains a significant clinical challenge. A study in this issue of the JCI describes an exciting application of high-throughput functional genomic technology to further refine our understanding of treatment failure risk in prostate cancer patients .

Documentos Relacionados

• Predicting the clinical status of human breast cancer by using gene expression profiles
• Gene expression profiling predicts clinical outcome of prostate cancer
• Clinical perspectives of PSMA PET/MRI for prostate cancer
• Controversy in clinical cancer screening--prostate-specific antigen.
• Clinical utility of prostate-specific antigen mass ratio for prediction of prostate cancer detection on a repeated prostate biopsy